February 13, 2020 / 12:27 PM / 5 days ago

BRIEF-Agios Reports Q4 Loss Per Share Of $1.60

Feb 13 (Reuters) - Agios Pharmaceuticals Inc:

* AGIOS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* Q4 REVENUE $35.4 MILLION VERSUS REFINITIV IBES ESTIMATE OF $33.7 MILLION

* FULL YEAR 2020 U.S. TIBSOVO NET REVENUE EXPECTED TO BE BETWEEN $105 MILLION -115 MILLION

* QTRLY LOSS PER SHARE $1.60

* Q4 EARNINGS PER SHARE VIEW $-1.72 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below